Mitchells Felder News Today

Halberds Traumatic Brain Injury (TBI) Testing Results Replicated at ...

Astounding Early Test Results of Halberds Traumatic Brain Injury (TBI) ...

Shares of Premier Biomedical, Inc. (OTCMKTS:BIEI – Get Rating) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.00 and traded as high as $0.00. Premier Biomedical shares last traded at $0.00, with a volume of 12,225,508 shares. Premier Biomedical Stock Down 9.1 […]

HALB CEO, CTO and YSUs Dr. Sturrus Discuss CDC, Research Discoveries ...

20.04.2023 - JACKSON CENTER, PA / ACCESSWIRE / April 20, 2023 / Halberd Corporations (OTC PINK:HALB) President & CEO, William A. Hartman, its Chief Technical Officer, Dr. Mitchell S. Felder, and Youngstown State University (YSU) Professor/lead researcher, Dr. ... Seite 1

JACKSON CENTER, PA / ACCESSWIRE / March 30, 2023 / Halberd Corporation (OTC PINK:HALB) and Mississippi State University (MSU) signed an agreement outlining the testing in pre-clinical models which will

Halberd's method shown previously to be effective on multiple strains of antibiotic resistant bacteria to be tested on CDC strains.JACKSON CENTER, PA / ACCESSWIRE / December 6, 2022 / Halberd Corporation

JACKSON CENTER, PA / ACCESSWIRE / December 1, 2022 / Halberd Corporation's (OTC-PINK:HALB) Covid research has led to a scientific article titled, "A Novel Plant-Made Monoclonal Antibody Enhances the Synergetic

01.12.2022 - Reason for correction - to correct percentages from rounded figures to more accurate actual numbers.Boosts effectiveness by 44.4% of commercially available Covid antibody in cocktailJACKSON CENTER, PA / ACCESSWIRE / December 1, 2022 / Halberd ...

Boosts effectiveness by 50% of commercially available Covid antibody in cocktailJACKSON CENTER, PA / ACCESSWIRE / November 30, 2022 / Halberd Corporation's (OTC PINK:HALB) Covid research has led to a scientific